Jo Bhakdi is an entrepreneur, economist, innovator, and the founder and CEO of Quantgene where he combines precision genomics, cloud, AI, and a new perspective on preventive medicine in order to protect and extend human life. Alongside Quantgene’s team of scientists and engineers, he is turning medicine into a predictive data science to enhance the effectiveness and accessibility of healthcare for everyone. His mission is to extend the healthy human life span by a decade within a decade.

As a child of medical scientists and doctors, Jo grew up with a backdrop of clinical research. He went on to earn a Master’s in Economics from Tubingen University, one of Germany’s leading academic institutions. Later in his career, he held executive positions at WPP and BDDO companies with a focus on strategy, innovation and technology. Launching his shift into innovating healthcare, Jo founded i2X in 2011, an investment platform that provides quantitative analytics for healthcare, biotechnology, and technology portfolios. 

In 2015 Jo founded Quantgene at UC Berkeley with the mission to detect cancer and other diseases early and protect human life. He has galvanized a team of scientists and technologists to push the boundaries of precision and preventive medicine. During the COVID Pandemic, Quantgene rapidly innovated laboratory, medical intelligence and operational infrastructures to protect hundreds of thousands of Americans with the nation’s leading detection and intelligence platform. 

With Serenity, their flagship product, Quantgene and Jo combine the world’s most advanced medical technologies to provide patients everywhere with an unprecedented level of personalized health protection. In 2022, Serenity, was awarded “Functional Genomics Innovation of the Year” at the BioTech Breakthrough Awards and became official community partner with the American Cancer Society. 

Jo has been a featured speaker at events such as Life Science Intelligence, StartUp Health Festival, UCLA Anderson’s School of Management and BioData West, and has been featured in publications such as Entrepreneur, Fortune, Healthline, NBC, and dotLA, as well as podcasts including Ark Invest and John Hopkins Biotech.